Skip to main content

Table 2 Details on LHRH tests performed in 2019 and 2020

From: Reduction in pediatric growth hormone deficiency and increase in central precocious puberty diagnoses during COVID 19 pandemics

  2019 2020
Normal Pathological Total Normal Pathological Total
Suspected diagnosis CPP 24 (50%) 24 (50%) 48 26 (49%) 28 (51%) 54
Females 22 16 38 19 26 45
Males 2 8 10 7 2 9
HH 13 (73%) 5 (27%) 18 26 (96%) 1 (4%) 27
  Total 66   81  
  1. CPP Central Precocious Puberty, HH Hypogonadotropic Hypogonadism